-
-
-
-
-
-
-
Needham Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
-
-
-
-
-
-
-
Ionis reports first quarter 2026 financial results and highlights progress on key programs
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Raised to $83 at Stifel
-
-
-
-
-
-
-
Ionis reports fourth quarter and full year 2025 financial results and highlights progress on key programs
-
-
-
-
-
-
-
H.C. Wainwright Starts Ionis Pharmaceuticals (IONS) at Buy
-
-
-
-
-
-
-
Ionis reports third quarter 2024 financial results
-
-
-
-
-
-
-
Laidlaw Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
-
15,895 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


